Show simple item record

dc.contributor.authorTouret, F, et al. Unité des Virus Emergents, UVE: Aix Marseille Univ.
dc.date.accessioned2020-03-20T17:59:39Z
dc.date.available2020-03-20T17:59:39Z
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0166354220301145en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/493
dc.description.abstractRecent publications have brought attention to the possible benefit of chloroquine, a broadly used antimalarial drug, in the treatment of patients infected by the novel emerged coronavirus (SARS-CoV-2). The scientific community should consider this information in light of previous experiments with chloroquine in the field of antiviral research.en_US
dc.subjectCOVID-19
dc.subjectCoronavirus
dc.subjectInfectious Diseases
dc.subjectSARS-CoV
dc.subjectChloroquine
dc.subjectHydroxychloroquine
dc.titleOf Chloroquine and COVID-19en_US
eihealth.countryOthersen_US
eihealth.categoryCandidate therapeutics RDen_US
eihealth.typeResearch protocol informationen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record